发明名称 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
摘要 In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): (I) and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R1, R2, R3, R4, R5, R9, ring A, ring B, m, n, p, -L1-, L2-, and L3- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (Aβ) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination nation with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimers disease, are also disclosed.;
申请公布号 US9428475(B2) 申请公布日期 2016.08.30
申请号 US201414221650 申请日期 2014.03.21
申请人 Merck Sharp & Dohme Corp. 发明人 Scott Jack D.;Stamford Andrew W.;Gilbert Eric J.;Cumming Jared N.
分类号 A61K31/549;C07D285/18;A61K31/00;A61K31/54;A61K45/06;C07D403/12;C07D401/14;C07D401/12;C07D403/04;C07D417/04;C07D417/12;C07D417/14;C07D471/04;C07D495/04;C07D213/89;C07D417/10;C07C309/30;C07D487/04;C07D213/26;A61K31/495;C07D239/14 主分类号 A61K31/549
代理机构 代理人 MacMillan Keith D.;Todaro John C.
主权项 1. A method of treating Alzheimer's disease in a human in need thereof comprising administering to the human a therapeutically effective amount of a compound, or a tautomer thereof, or a pharmaceutically acceptable salt of said compound or said tautomer, said compound selected from the group consisting of:
地址 Rahway NJ US